Cellebrite DI (CLBT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Cellebrite DI (CLBT) last issued guidance on August 13, 2026 for fiscal year 2026. The company guided revenue in the range of $555M - $561M for the period.
Compared to prior guidance, Cellebrite DI lowered its revenue forecast from a prior range of $565M - $571M.
Cellebrite DI has issued 27 guidance updates between November 17, 2022 and August 13, 2026. During this period, the company raised its outlook 8 times and lowered it 13 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.11 | $0.09 | $0.13 | $0.12 |
| Actual | $0.11 | $0.12 | $0.14 | $0.14 |
| Surprise | 0.00% | +33.3% | +7.69% | +16.7% |
| Revenue | ||||
| Estimate | $132.1M | $127.1M | $126.5M | $123.1M |
| Actual | $131.1M | $128.3M | $128.8M | $126.0M |
| Surprise | -0.71% | +0.98% | +1.81% | +2.37% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.15 | $0.17 | $0.12 | $0.12 |
| Revenue | ||||
| Consensus | $145.8M | $151.6M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $0.11 | $0.11 | 0.00 % |
| Q1 | May 14, 2026 | $0.12 | $0.09 | 33.3 % |
| Q4 | Feb 11, 2026 | $0.14 | $0.13 | 7.69 % |
| Q3 | Nov 12, 2025 | $0.14 | $0.12 | 16.7 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $131.14M | $132.07M | -0.71 % |
| Q1 | May 14, 2026 | $128.30M | $127.05M | 0.98 % |
| Q4 | Feb 11, 2026 | $128.82M | $126.53M | 1.81 % |
| Q3 | Nov 12, 2025 | $126.03M | $123.11M | 2.37 % |